CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Angiotech Pharmaceuticals, Inc. (USA) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Angiotech Pharmaceuticals, Inc. (USA)
355 Burrard Street, Ste. 1100
Phone: (604) 221-7676p:604 221-7676 Vancouver, BC  V6C 2G8  Canada Fax: (604) 221-2330f:604 221-2330

This company ceased filing statements with the SEC on 1/11/2013.
This company is no longer actively traded on any major stock exchange.

Business Summary
Angiotech Pharmaceuticals, Inc. is a developer and manufacturer of branded, private label, and OEM surgical instruments. The Company offers a comprehensive portfolio of blades and sutures, including products such as the Quill Knotless Tissue-Closure Device. Headquartered in Vancouver, CA, it services the needs of the specialty surgery market, having partnerships within dental, ophthalmic, plastic surgery, dermatology, orthopedics, urology, microsurgery, veterinary and trauma specialties. The Company has manufacturing facilities in England, Puerto Rico, Mexico and Germany, and sells to customers in over 80 countries.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201212/31/2012YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Co-Chairman of the Board Kurt M.Cellar 42 5/12/2011 5/12/2011
Independent Co-Chairman of the Board Jeffrey D.Goldberg 46 5/12/2011 5/12/2011
Interim President and Chief Executive Officer K. ThomasBailey 43 10/21/2011 12/19/2005
7 additional Officers and Directors records available in full report.

Business Names
Business Name
/Angiotech Pharmaceuticals, Inc. (USA)
American Medical Instruments Holdings, Inc.
Angiodevice International GmbH
25 additional Business Names available in full report.

General Information
Stock Exchange: OTC
Fax Number: (604) 221-2330
Email Address: info@angio.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023